Here’s what we know about Regeneron’s antibody cocktail.
What Is An Antibody Cocktail?
Polyclonal antibodies can restore, enhance, or mimic the immune system’s form of attack.
Drew Angerer/Staff / Getty Images
These antibodies can also potentially treat an existing infection.
Findings Are Preliminary
On Tuesday, Regeneron announced promising results for its antibody cocktail, called REGN-COV2.
Who Can Get It?
Regeneron plans to rapidly discuss initial clinical trial results with regulatory authorities.
For the most recent updates on COVID-19, visit ourcoronavirus news page.
PR Newswire.Regeneron Begins First Clinical Trials of Anti-Viral Antibody Cocktail REGN-COV2 for the Treatment and Prevention of COVID-19.
June 11, 2020.
Regeneron.Regeneron’s REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-hospitalized COVID-19 Patients.
September 29, 2020.
Mayo Clinic.I’ve Heard That Compassionate Use is a Way to Get Access to Experimental Treatments.
How Does it Work?February 12, 2020.
